Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Medtronic's hydrocephalus valve:

This article was originally published in Clinica

Executive Summary

Medtronic Neurosurgery has launched in the US its implantable Strata valve for shunting, or draining, excess cerebrospinal fluid from the brain of people with hydrocephalus, after gaining FDA 510(k) clearance for the device. Unlike traditional valves, the new device enables clinicians to adjust its five pressure settings noninvasively and without the need for X-ray verification as the patient's condition changes, says the company. These features could also reduce the frequency of valve replacements. The Strata valve also protects against excess drainage of cerebrospinal fluid, a complication that can lead to tissue tears or bleeding in the brain. Around 160,000 people worldwide are estimated to receive a hydrocephalus shunt annually.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065027

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel